PI3K/AKT pathway-mediated regulation of p27Kip1 is associated with cell cycle arrest and apoptosis in cervical cancer

Cellular Oncology

Volumn 38, Issue 3, 2015, Pages 215-225

  Prasad, Shyam Babu ^a   Yadav, Suresh Singh ^a   Das, Mitali ^a   Modi, Arusha ^a   Kumari, Soni ^a   Pandey, Lakshmi Kant ^a   Singh, Sunita ^a   Pradhan, Satyajit ^a   Narayan, Gopeshwar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Apoptosis; Cell cycle; p27Kip1; PI3K AKT

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLIN DEPENDENT KINASE INHIBITOR 1B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; CDKN1B PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIDDLE AGED; MTT ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING; CELL CYCLE CHECKPOINT; HELA CELL LINE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ADULT; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE CHECKPOINTS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 84929948203     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-015-0224-x     Document Type: Article

References (51)

1. D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell 100, 57–70 (2000)
2. C.J. Sherr, Cancer cell cycles. Science 274, 1672–1677 (1996)
3. J. Slingerland, M. Pagano, Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183, 10–17 (2000)
4. K. Polyak, J.Y. Kato, M.J. Solomon, C.J. Sherr, J. Massague, J.M. Roberts, A. Koff, p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8, 9–22 (1994)
5. B. St, V.A. Croix, J.W. Florenes, M. Rak, N. Flanagan, J.M. Bhattacharya, R.S.K. Slingerland, Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anti cancer agents. Nat Med 2, 1204–1210 (1996)
6. G.V. Thomas, K. Szigeti, M. Murphy, G. Draetta, M. Pagano, M. Loda, Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol 153, 681–687 (1998)
7. H. Toyoshima, T. Hunter, p27, a novel inhibitor of G1 cyclin–CDK protein kinase activity, is related to p21. Cell 78, 67–74 (1994)
8. J. Philipp-Staheli, S.R. Payne, C.J. Kemp, p27Kip1: Regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res 264, 148–168 (2001)
9. M.L. Fero, M. Rivkin, M. Tasch, P. Porter, C.E. Carow, E. Firpo, K. Polyak, L.H. Tsai, V. Broudy, R.M. Perlmutter, K. Kaushansky, J.M. Roberts, A syndrome of multi organ hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85, 733–744 (1996)
10. S. Kang, S.M. Dong, B.R. Kim, M.S. Park, B. Trink, H.J. Byun, S.B. Rho, Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells. Apoptosis 17, 989–997 (2012)
11. B. Durand, F.B. Gao, M. Raff, Accumulation of the cyclin-dependent kinase inhibitor p27Kip1 and the timing of oligodendrocyte differentiation. Embo J 16, 306–317 (1997)
12. B. Levkau, H. Koyama, E.W. Raines, B.E. Clurman, B. Herren, K. Orth, J.M. Roberts, R. Ross, Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell 1, 553–563 (1998)
13. G.V. DePutte, R. Holm, A.K. Lie, C.G. Trope, G.B. Kristensen, Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol Oncol 89, 140–147 (2003)
14. J. Bouda, O. Hes, M. Koprivova, M. Pesek, T. Svoboda, L. Boudova, P27 as a prognostic factor of early cervical carcinoma. Int J Gynecol Cancer 23, 164–169 (2013)
15. M.V. Ponce-Castaneda, M.H. Lee, E. Latres, K. Polyak, L. Lacombe, K. Montgomery, S. Mathew, K. Krauter, J. Sheinfeld, J. Massague, C. Cordon-Cardo, p27Kip1: chromosomal mapping to 12p12–12p13.1 and absence of mutations in human tumors. Cancer Res 55, 1211–1214 (1995)
16. X. Qian, L. Jin, E. Kulig, R.V. Lloyd, DNA methylation regulates p27kip1 expression in rodent pituitary cell lines. Am J Pathol 153, 1475–1482 (1998)
17. M. Pagano, S.W. Tam, A.M. Theodoras, P. Beer-Romero, G.D. Sal, V. Chau, P.R. Yew, G.F. Draetta, M. Rolfe, Role of the ubiquitin–proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682–705 (1995)
18. A. Montagnoli, F. Fiore, E. Eytan, A.C. Carrano, G.F. Draetta, A. Hershko, M. Pagano, Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes & Dev 13, 1181–1189 (1999)
19. M. Shirane, Y. Harumiya, N. Ishida, A. Hirai, C. Miyamoto, S. Hatakeyama, K. Nakayama, M. Kitagawa, Down-regulation of p27Kip1 by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 274, 13886–13893 (1999)
20. I. Perez-Roger, D.L.C. Solomon, A. Sewing, H. Land, Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes. Oncogene 14, 2373–2381 (1997)
21. R.J. Sheaff, M. Groudine, M. Gordon, J.M. Roberts, B.E. Clurman, Cyclin E CDK2 is a regulator of p27Kip1. Genes & Dev 11, 1464–1478 (1997)
22. A.C. Carrano, E. Eytan, A. Hershko, M. Pagano, SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nature Cell Biol 1, 193–199 (1999)
23. H. Sutterluty, E. Chatelain, A. Marti, C. Wirbelauer, M. Senften, U. Müller, W. Krek, p45Skp2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nature Cell Biol 1, 207–214 (1999)
24. G. Viglietto, M.L. Motti, P. Bruni, R.M. Melillo, A.D. Alessio, D. Califano, F. Vinci, G. Chiappetta, P. Tsichlis, A. Bellacosa, A. Fusco, M. Santoro, Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8, 1136–1144 (2002)
25. B. Vanhaesebroeck, D.R. Alessi, The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346, 561–576 (2000)
26. J.A. Fresno-Vara, E. Casado, J. de Castro, P. Cejas, C. Belda-Iniesta, M. Gonzalez-Baron, PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30, 193–204 (2004)
27. J. Liang, J.M. Slingerland, Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2, 339–345 (2003)
28. K.R. Auger, L.A. Serunian, S.P. Soltoff, P. Libby, L.C. Cantley, PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57, 167–175 (1989)
29. J. Liang, J. Zubovitz, T. Petrocelli, R. Kotchetkov, M.K. Connor, K. Han, J.H. Lee, S. Ciarallo, C. Catzavelos, R. Beniston, E. Franssen, J.M. Slingerland, PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nature Med 8, 1153–1160 (2002)
30. Y. Narita, M. Nagane, K. Mishima, H.J. Huang, F.B. Furnari, W.K. Cavenee, Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of phosphatidylinositol 3-Kinase/Akt pathway in glioblastomas. Cancer Res 62, 6764–6769 (2002)
31. F.M. Yakes, W. Chinratanalab, C.A. Ritter, W. King, S. Seelig, C.L. Arteaga, Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action. Cancer Res 62, 4132–4141 (2002)
32. I. Shin, F.M. Yakes, F. Rojo, N.Y. Shin, A.V. Bakin, J. Baselga, C.L. Arteaga, PKB/Akt mediates cell cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8, 1145–1152 (2002)
33. S.T. Charette, D.J. McCance, The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Akt-dependent manner. Oncogene 26, 7386–7390 (2007)
34. F.E. Henken, N.S. Banerjee, P.J.F. Snijders, C.J.L.M. Meijer, J. De-Castro Arce, F. Rosl, T.R. Broker, L.T. Chow, R.D.M. Steenbergen, PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro. Mol Cancer 10, 71 (2011)
35. C.P. Harris, X.Y. Lu, G. Narayan, B. Singh, V.V. Murty, P.H. Rao, Comprehensive molecular cytogenetic characterization of cervical carcinoma cell lines. Genes Chrom Cancer 36, 233–2341 (2003)
36. G. Narayan, L. Scotto, V. Neelakantan, S.H. Kottoor, A.H. Wong, S.L. Loke, M. Mansukhani, B. Pothuri, J.D. Wright, A.M. Kaufmann, A. Schneider, H. Arias-Pulido, Q. Tao, V.V. Murty, Promoter hypermethylation of FANCF: Disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res 64, 2994–2997 (2004)
37. G. Narayan, C. Goparaju, H. Arias-Pulido, A.M. Kaufmann, A. Schneider, M. Dürst, M. Mansukhani, B. Pothuri, V.V. Murty, Promoter hypermethylation-mediated inactivation of multiple Slit-Robo genes in cervical cancer progression. Mol Cancer 5, 16 (2006)
38. G. Narayan, L. Scotto, V. Neelakantan, S.H. Kottoor, A.H.Y. Wong, S.-L. Loke, M. Mansukhani, B. Pothuri, J.D. Wright, A.M. Kaufmann, A. Schneider, H. Arias-Pulido, Q. Tao, V.V. Murty, Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer. Genes Chrom Cancer 48, 983–992 (2009)
39. M. Das, S.B. Prasad, S.S. Yadav, H.B. Govardhan, L.K. Pandey, S. Singh, S. Pradhan, G. Narayan, Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis. PLoS One 8, e69607 (2013)
40. S. Kulkarni, J.S. Rader, F. Zhang, H. Liapis, A.T. Koki, J.L. Masferrer, K. Subbaramaiah, A.J. Dannenberg, Cyclooxygenase-2 overexpressed in human cervical cancer. Clin Cancer Res 7, 429–434 (2001)
41. M. Stahl, P.F. Dijkers, G.J. Kops, S.M. Lens, P.J. Coffer, B.M. Burgering, R.H. Medema, The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol 168, 5024–5031 (2002)
42. K.Y. Tae, C.E. Kyoung, C.N. Hoon, K.J. Hung, Y.W. Ick, K.J. Wook, S. HoL, Expression of cyclin E and p27 (KIP1) in cervical carcinoma. Cancer Lett 153, 41–50 (2000)
43. N. Rivard, G.L. Allemain, J. Bartek, J. Pouyssegur, Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J Biol Chem 271, 18337–18341 (1996)
44. S.B. Prasad, S.S. Yadav, M. Das, H.B. Govardhan, L.K. Pandey, S. Singh, S. Pradhan, G. Narayan, Down regulation of FOXO1 promotes cell proliferation in cervical cancer. J Cancer 5, 655–622 (2014)
45. R.H. Medema, G.J. Kops, J.L. Bos, B.M. Burgering, AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404, 782–787 (2000)
46. G.Z. Rassidakis, M. Feretzaki, C. Atwell, I. Grammatikakis, Q. Lin, R. Lai, F.X. Claret, L.J. Medeiros, H.M. Amin, Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma. Blood 105, 827–829 (2005)
47. I. Mikami, F. Zhang, T. Hirata, J. Okamoto, K. Koizumi, K. Shimizu, D. Jablons, B. He, Inhibition of activated phosphatidylinositol 3-kinase/AKT pathway in malignant pleural mesothelioma leads to G1 cell cycle arrest. Oncology Rep 24, 1677–1681 (2010)
48. Y.H. Han, H.J. Moon, B. You, W.H. Park, The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH. Oncology Rep 22, 215–221 (2009)
49. X.F. Zhu, Z.C. Liu, B.F. Xie, G.K. Feng, Y.X. Zeng, Ceramide induces cell cycle arrest and upregulates p27kip in nasopharyngeal carcinoma cells. Cancer Lett 193, 149–154 (2003)
50. B. Wagenknecht, M. Hermisson, K. Eitel, M. Weller, Proteasome inhibitors induce p53/p21- independent apoptosis in human glioma cells. Cell Physiol Biochem 9, 117–125 (1999)
51. B. Wagenknecht, M. Hermisson, P. Groscurth, P. Liston, P.H. Krammer, M. Weller, Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem 75, 2288–2297 (2000)